To better understand the genes with altered expression caused by infection with the novel coronavirus strain SARS-CoV-2 causing COVID-19 infectious disease, a tensor decomposition (TD)-based unsupervised feature extraction (FE) approach was applied to a gene expression profile dataset of the mouse liver and spleen with experimental infection of mouse hepatitis virus, which is regarded as a suitable model of human coronavirus infection. TD-based unsupervised FE selected 134 altered genes, which were enriched in protein-protein interactions with orf1ab, polyprotein, and 3C-like protease that are well known to play critical roles in coronavirus infection, suggesting that these 134 genes can represent the coronavirus infectious process. We then selected compounds targeting the expression of the 134 selected genes based on a public domain database. The identified drug compounds were mainly related to known antiviral drugs, several of which were also included in those previously screened with an in silico method to identify candidate drugs for treating COVID-19.
Keyphrases
- sars cov
- genome wide
- respiratory syndrome coronavirus
- gene expression
- genome wide identification
- endothelial cells
- coronavirus disease
- machine learning
- poor prognosis
- dna methylation
- protein protein
- bioinformatics analysis
- healthcare
- genome wide analysis
- copy number
- mental health
- drug delivery
- transcription factor
- long non coding rna
- cancer therapy
- metal organic framework
- aqueous solution